Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model

Samar Masoumi Moghaddam, Kristen Starbuck, Robert McGray, Ariel Francois, Kunle Odunsi, Emese Zsiros

Research output: Contribution to conferencePoster

Original languageEnglish
Pages956
DOIs
Publication statusPublished - Jul 2017
EventAmerican Association for Cancer Research Annual Meeting 2017 - Washington, United States of America
Duration: 1 Apr 20175 Apr 2017

Conference

ConferenceAmerican Association for Cancer Research Annual Meeting 2017
Abbreviated titleAACR
CountryUnited States of America
CityWashington
Period1/04/175/04/17

Cite this

Masoumi Moghaddam, S., Starbuck, K., McGray, R., Francois, A., Odunsi, K., & Zsiros, E. (2017). Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model. 956. Poster session presented at American Association for Cancer Research Annual Meeting 2017, Washington, United States of America. https://doi.org/10.1158/1538-7445.AM2017-956